Yoon Miri, Zago Anna, Shukla Deepak, Spear Patricia G
Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
J Virol. 2003 Sep;77(17):9221-31. doi: 10.1128/jvi.77.17.9221-9231.2003.
Multiple cell surface molecules (herpesvirus entry mediator [HVEM], nectin-1, nectin-2, and 3-O-sulfated heparan sulfate) can serve as entry receptors for herpes simplex virus type 1 (HSV-1) or HSV-2 and also as receptors for virus-induced cell fusion. Viral glycoprotein D (gD) is the ligand for these receptors. A previous study showed that HVEM makes contact with HSV-1 gD at regions within amino acids 7 to 15 and 24 to 32 at the N terminus of gD. In the present study, amino acid substitutions and deletions were introduced into the N termini of HSV-1 and HSV-2 gDs to determine the effects on interactions with all of the known human and mouse entry/fusion receptors, including mouse HVEM, for which data on HSV entry or cell fusion were not previously reported. A cell fusion assay was used to assess functional activity of the gD mutants with each entry/fusion receptor. Soluble gD:Fc hybrids carrying each mutation were tested for the ability to bind to cells expressing the entry/fusion receptors. We found that deletions overlapping either or both of the HVEM contact regions, in either HSV-1 or HSV-2 gD, severely reduced cell fusion and binding activity with all of the human and mouse receptors except nectin-1. Amino acid substitutions described previously for HSV-1 (L25P, Q27P, and Q27R) were individually introduced into HSV-2 gD and, for both serotypes, were found to be without effect on cell fusion and the binding activity for nectin-1. Each of these three substitutions in HSV-1 gD enhanced fusion with cells expressing human nectin-2 (ordinarily low for wild-type HSV-1 gD), but the same substitutions in HSV-2 gD were without effect on the already high level of cell fusion observed with the wild-type protein. The Q27P or Q27R substitution in either HSV-1 and HSV-2 gD, but not the L25P substitution, significantly reduced cell fusion and binding activity for both human and mouse HVEM. Each of the three substitutions in HSV-1 gD, as well as the deletions mentioned above, reduced fusion with cells bearing 3-O-sulfated heparan sulfate. Thus, the N terminus of HSV-1 or HSV-2 gD is not necessary for functional interactions with nectin-1 but is necessary for all of the other receptors tested here. The sequence of the N terminus determines whether nectin-2 or 3-O-sulfated heparan sulfate, as well as HVEM, can serve as entry/fusion receptors.
多种细胞表面分子(疱疹病毒进入介质[HVEM]、nectin-1、nectin-2和3-O-硫酸化硫酸乙酰肝素)可作为1型单纯疱疹病毒(HSV-1)或2型单纯疱疹病毒(HSV-2)的进入受体,也可作为病毒诱导的细胞融合受体。病毒糖蛋白D(gD)是这些受体的配体。先前的一项研究表明,HVEM在gD N端氨基酸7至15以及24至32区域与HSV-1 gD接触。在本研究中,将氨基酸取代和缺失引入HSV-1和HSV-2 gD的N端,以确定对与所有已知的人类和小鼠进入/融合受体相互作用的影响,包括小鼠HVEM,此前尚未报道其关于HSV进入或细胞融合的数据。采用细胞融合试验评估gD突变体与每种进入/融合受体的功能活性。测试携带每种突变的可溶性gD:Fc杂合体与表达进入/融合受体的细胞结合的能力。我们发现,HSV-1或HSV-2 gD中与HVEM接触区域之一或两者重叠的缺失,严重降低了与除nectin-1之外的所有人类和小鼠受体的细胞融合及结合活性。先前描述的HSV-1的氨基酸取代(L25P、Q27P和Q27R)被分别引入HSV-2 gD,并且对于两种血清型,发现这些取代对细胞融合及与nectin-1的结合活性没有影响。HSV-1 gD中的这三种取代中的每一种都增强了与表达人类nectin-2的细胞的融合(野生型HSV-1 gD通常较低),但HSV-2 gD中的相同取代对野生型蛋白观察到的已经很高水平的细胞融合没有影响。HSV-1和HSV-2 gD中的Q27P或Q27R取代,但不是L25P取代,显著降低了与人类和小鼠HVEM的细胞融合及结合活性。HSV-1 gD中的三种取代中的每一种以及上述缺失,都降低了与携带3-O-硫酸化硫酸乙酰肝素的细胞的融合。因此,HSV-1或HSV-2 gD的N端对于与nectin-1的功能相互作用不是必需的,但对于此处测试的所有其他受体是必需的。N端序列决定了nectin-2或3-O-硫酸化硫酸乙酰肝素以及HVEM是否可作为进入/融合受体。